A massive valuation for a "seed" round can be misleading. Often, insiders have participated in several unannounced, cheaper tranches. The headline number is just the final, most expensive tier, used to create FOMO and set a high watermark for new investors.

At the seed stage, if you're right about a truly exceptional company, the entry valuation hardly matters. Gokul cites a 200x return on an expensive seed deal. However, by Series B, a high price can crush your multiple, even if the company continues to perform well.

Large, multi-stage funds can pay any price for seed rounds because the check size is immaterial to their fund's success. They view seed investments not on their own return potential, but as an option to secure pro-rata rights in future, massive growth rounds.

The early-stage venture market has split into two extremes, eliminating the middle ground. Deals are either priced for hype at massive valuations (e.g., a $50M pre-seed round) or are considered bargains at very low valuations (e.g., $2-5M), forcing investors to choose a side.

The bar for pre-seed funding has risen dramatically. With an abundance of startups already generating revenue (e.g., $1M ARR), VCs are choosing these de-risked opportunities over pure idea-stage companies. This "flight to quality" has bifurcated the market, making it extremely difficult for pre-revenue founders to raise.

Venture rounds are compressing and conflating, with massive "seed" rounds of $30M+ essentially combining a seed and Series A. This sets a dangerous trap: the expectations for your next funding round will be equivalent to those of a traditional Series B company, dramatically raising the bar for growth.

AI companies raise subsequent rounds so quickly that little is de-risked between seed and Series B, yet valuations skyrocket. This dynamic forces large funds, which traditionally wait for traction, to compete at the earliest inception stage to secure a stake before prices become untenable for the risk involved.

Setting an overly optimistic valuation for a pre-revenue friends-and-family round can create a 'valuation trap.' If you later need a structured seed round from an accelerator with standardized (and likely lower) terms, your initial investors may veto the necessary 'down round,' killing the deal and your access to capital.

The classic seed strategy of investing in a founder in a small market and hoping they "stair-step" into a larger Total Addressable Market (TAM) is no longer viable. With entry valuations at $60M+, investors must believe the opportunity is already massive enough to justify a $20B+ outcome to make the math work.